司妥昔单抗 T76978

Product Introduction
Bioactivity


英文名: Siltuximab

描述: Siltuximab（CNTO-328） 是一种靶向 IL-6 且具有抗肿瘤活性的单克隆抗体，可用于研究巨大淋巴结增生症 (MCD) 和 COVID-19。

体内活性: In xenograft mouse models, Siltuximab, when administered through intraperitoneal injection at a dosage of 10 mg/kg three times per week, inhibits the growth of lung cancer cells[1]. Furthermore, in a xenograft model, the growth of MCF-7 tumors is inhibited by Siltuximab with intraperitoneal injections at a dose of 20 mg/kg twice per week for 6 weeks[3].

存储条件: store at low temperaturestore at -80°C

相关产品: Platycodin D2 | N-Decyl-4-methoxyaniline | GSK717 | Myristicin | Carpinontriol B | Neoisoastilbin | 6,4'-Dihydroxy-7-methoxyflavanone | SDZ 224-015 | BIRT-377 | Ilexgenin A

司妥昔单抗 T76978信息由TargetMol中国为您提供，如您想了解更多关于司妥昔单抗 T76978报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途